News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
250,372 Results
Type
Article (6214)
Company Profile (23)
Press Release (244135)
Section
Business (89055)
Career Advice (478)
Deals (16720)
Drug Delivery (12)
Drug Development (21715)
Employer Resources (37)
FDA (4155)
Job Trends (4708)
News (132056)
Policy (8621)
Tag
Academia (379)
Accelerated approval (2)
Adcomms (3)
Allergies (9)
Alliances (16625)
ALS (22)
Alzheimer's disease (328)
Antibody-drug conjugate (ADC) (16)
Approvals (4176)
Artificial intelligence (49)
Autoimmune disease (6)
Automation (3)
Bankruptcy (109)
Best Places to Work (3485)
Biosimilars (12)
Biotechnology (30)
Bladder cancer (12)
Brain cancer (8)
Breast cancer (72)
Cancer (534)
Cardiovascular disease (27)
Career advice (410)
Career pathing (3)
CAR-T (37)
Cell therapy (118)
Cervical cancer (2)
Clinical research (18151)
Collaboration (203)
Compensation (173)
Complete response letters (3)
COVID-19 (472)
CRISPR (9)
C-suite (116)
Cystic fibrosis (17)
Data (607)
Depression (10)
Diabetes (50)
Diagnostics (2305)
Digital health (3)
Diversity, equity & inclusion (14)
Drug discovery (29)
Drug pricing (7)
Drug shortages (1)
Duchenne muscular dystrophy (12)
Earnings (43179)
Editorial (2)
Employer branding (6)
Employer resources (36)
Events (41284)
Executive appointments (337)
FDA (4441)
Fibrodysplasia Ossificans Progressiva (1)
Frontotemporal dementia (2)
Funding (240)
Gene editing (18)
Generative AI (2)
Gene therapy (56)
GLP-1 (131)
Government (549)
Guidances (21)
Healthcare (5729)
Huntington's disease (1)
IgA nephropathy (4)
Immunology and inflammation (13)
Indications (7)
Infectious disease (492)
Inflammatory bowel disease (24)
Inflation Reduction Act (2)
Influenza (3)
Intellectual property (17)
Interviews (58)
IPO (8494)
IRA (5)
Job creations (1319)
Job search strategy (373)
Kidney cancer (7)
Labor market (5)
Layoffs (113)
Leadership (5)
Legal (2752)
Liver cancer (17)
Lung cancer (58)
Lymphoma (37)
Management (13)
Manufacturing (63)
MASH (29)
Medical device (4384)
Medtech (4386)
Mergers & acquisitions (8470)
Metabolic disorders (135)
Multiple sclerosis (12)
NASH (6)
Neurodegenerative disease (14)
Neuropsychiatric disorders (2)
Neuroscience (448)
NextGen: Class of 2025 (1879)
Non-profit (865)
Now hiring (4)
Obesity (55)
Opinion (31)
Ovarian cancer (17)
Pain (18)
Pancreatic cancer (21)
Parkinson's disease (29)
Partnered (10)
Patents (29)
Patient recruitment (35)
Peanut (5)
People (26886)
Pharmaceutical (8)
Pharmacy benefit managers (1)
Phase I (5402)
Phase II (7989)
Phase III (6220)
Pipeline (598)
Policy (13)
Postmarket research (680)
Preclinical (2181)
Press Release (67)
Prostate cancer (29)
Psychedelics (5)
Radiopharmaceuticals (120)
Rare diseases (76)
Real estate (2142)
Recruiting (11)
Regulatory (5753)
Reports (15)
Research institute (380)
Resumes & cover letters (68)
Rett syndrome (4)
RNA editing (1)
Schizophrenia (27)
Series A (34)
Series B (25)
Service/supplier (2)
Sickle cell disease (9)
Special edition (1)
Spinal muscular atrophy (30)
Sponsored (5)
Startups (1175)
State (1)
Stomach cancer (1)
Supply chain (12)
Tariffs (6)
Vaccines (62)
Venture capitalists (5)
Weight loss (24)
Women's health (1)
Date
Today (60)
Last 7 days (268)
Last 30 days (821)
Last 365 days (11228)
2025 (3642)
2024 (12385)
2023 (14738)
2022 (20722)
2021 (22221)
2020 (20073)
2019 (14724)
2018 (11334)
2017 (11088)
2016 (10241)
2015 (13430)
2014 (10562)
2013 (8583)
2012 (9268)
2011 (9678)
2010 (9482)
Location
Africa (209)
Alabama (15)
Alaska (2)
Arizona (67)
Arkansas (1)
Asia (12363)
Australia (1705)
California (2076)
Canada (1110)
China (83)
Colorado (94)
Connecticut (107)
Delaware (35)
Europe (26528)
Florida (304)
Georgia (39)
Idaho (23)
Illinois (129)
India (7)
Indiana (81)
Iowa (2)
Japan (81)
Kansas (25)
Kentucky (13)
Louisiana (5)
Maine (40)
Maryland (232)
Massachusetts (1705)
Michigan (106)
Minnesota (148)
Mississippi (1)
Missouri (23)
Montana (16)
Nebraska (14)
Nevada (26)
New Hampshire (24)
New Jersey (725)
New Mexico (8)
New York (545)
North Carolina (365)
North Dakota (3)
Northern California (980)
Ohio (62)
Oklahoma (7)
Oregon (5)
Pennsylvania (401)
Puerto Rico (2)
Rhode Island (13)
South America (317)
South Carolina (6)
Southern California (747)
Tennessee (45)
Texas (281)
United States (7899)
Utah (64)
Virginia (47)
Washington D.C. (9)
Washington State (184)
West Virginia (2)
Wisconsin (36)
250,372 Results for "kinetic river corp".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Charles River Announces Inaugural Advanced Therapy Incubator Program Cohort
April 30, 2025
·
6 min read
Press Releases
Charles River Leverages Advanced Technology to Expedite Oncology Drug Discovery and Development
April 22, 2025
·
6 min read
Press Releases
Charles River Laboratories Schedules First-Quarter 2025 Earnings Release and Conference Call
April 15, 2025
·
1 min read
Press Releases
Charles River Laboratories to Present at Barclays Global Healthcare Conference
March 11, 2025
·
1 min read
Press Releases
Charles River Announces Agreement with Singapore General Hospital
February 25, 2025
·
3 min read
Press Releases
Charles River and Valo Health Identify a Potential Therapeutic for Lupus Using Logica®, an AI-Powered Drug Discovery Platform
March 26, 2025
·
4 min read
Press Releases
FairJourney Biologics Acquires Charles River Laboratories South San Francisco Facility
March 4, 2025
·
2 min read
BioCapital
Charles River Laboratories Publishes 2023 Corporate Citizenship Report
Charles River Laboratories International, Inc. announced the publication of its 2023 Corporate Citizenship Report, which includes progress and results from 2022 and 2023.
March 27, 2024
·
5 min read
Press Releases
180 Life Sciences Corp. Announces Share Repurchase
April 30, 2025
·
7 min read
Press Releases
Charles River Expands Apollo™ Ecosystem, Offering Bespoke Client Experiences
January 21, 2025
·
4 min read
1 of 25,038
Next
